Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Terminated1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT01267240Phase 2Terminated
Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
Paranasal Sinus Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+14 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Shlomo Koyfman

Case Comprehensive Cancer Center

Related
1 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Oral Cavity Squamous Cell Carcinoma+13 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score28%

Chandylen Nightingale

Wake Forest University Health Sciences

Related
1 trials

Shared therapeutic areas:

Paranasal Sinus Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+9 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score21%

Jennifer Johnson, MD, PhD

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Related
5 trials

Shared therapeutic areas:

Stage IVA Hypopharyngeal Squamous Cell CarcinomaStage IVA Laryngeal Squamous Cell CarcinomaStage IVA Oral Cavity Squamous Cell Carcinoma+9 more
Similarity Score21%

Eric Winquist

University Health Network Princess Margaret Cancer Center P2C

Related
1 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma+6 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score16%

Tanguy Seiwert

University of Chicago Comprehensive Cancer Center P2C

Related
1 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma+6 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score16%

Nicole C Schmitt, MD, FACS

Emory University Hospital/Winship Cancer Institute

Related
1 trials

Shared therapeutic areas:

Paranasal Sinus Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Nabil F. Saba, MD

Emory University

Related
2 trials

Shared therapeutic areas:

Paranasal Sinus Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Mercedes Porosnicu

Wake Forest University Health Sciences

Related
2 trials

Shared therapeutic areas:

Stage IVA Oral Cavity Squamous Cell CarcinomaStage IVA Oropharyngeal Squamous Cell CarcinomaStage IVB Oral Cavity Squamous Cell Carcinoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Greg Wolf

University of Michigan Rogel Cancer Center

Related
1 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Siddharth Sheth

Alliance for Clinical Trials in Oncology

Related
1 trials

Shared therapeutic areas:

Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Oral Cavity Squamous Cell Carcinoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01267240Phase 2PrincipalInvestigator

Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Paranasal Sinus Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+14 more
Terminated

All 1 trials loaded